Skip to main content

Table 1 Demographic/clinical data of study individuals.

From: Preserving the B-Cell Compartment Favors Operational Tolerance in Human Renal Transplantation

Study individual OT1 OT2 OT3 OT4 OT5 CR Group (n = 13) Sta group (n = 19) HI group (n = 11)
Age (years) 53 42 43 49 32 44 (27–64) 50 (25–78) 41 (30–57)
Sex (F, M) M M F F M 4, 9 10, 9 6, 5
Number of grafts 1 2 1 1 1 1 (n = 13) 2 (n = 1) 1 (n = 18) NA
Time of transplantation (years) 23 5 7 23 13 8 (4–13) 8 (1–34) NA
Induction therapy NA Anti-CD25 No No No 5 of 13 Anti-CD25 = 4 ATG = 1 14 of 19 Anti-CD25 = 13 ATG + IVIG = 1 NA
HLA (A, B, DR) mismatches 3 4 0 0 3 4.45 ± 1.75 (n = 11) NA (n = 2) 3.83 ± 1.30 (n = 18) NA (n = 1) NA
Donor (living, deceased) Living Deceased Living Living Living 6, 7 16, 3 NA
Blood transfusion (Y, N) NA Y N Y N 6, 3 NA (n = 4) 11, 3 NA (n = 5) NA
Acute rejection episode (Y, N) N Y N N N 8, 5 6, 13 NA
Viral infections (Y, N) NA Y NA N N 7, 5 4, 15 NA
Reason for immunosuppression interruption Non-compliance Non-compliance Non-compliance Non-compliance Non-compliance NA NA NA
Drug-free time (years) 6 1.5 4.1 8 4 NA NA NA
  1. ATG, antithymocyte globulin; NA, not available or does not apply; IVIG, intravenous immunoglobulin. The numeric data are represented as mean ± standard deviation. Age (years): the age range for each group is shown in the parentheses. Time of transplantation: the time range is shown in the parentheses.